A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects (Q34573282)

3 August 2017

1 reference

title

A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects (English)

1 reference

3 August 2017

1 reference

1 reference

O'Connell D

1

1 reference

3 August 2017

Robertson J

series ordinal

2

1 reference

3 August 2017

Henry D

series ordinal

3

1 reference

3 August 2017

Gillespie W

series ordinal

4

1 reference

3 August 2017

1 June 1998

1 reference

3 August 2017

1 reference

3 August 2017

1

1 reference

3 August 2017

2

1 reference

3 August 2017

112-123

1 reference

A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995.

3 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Calcitonin and lumbar bone mineral content during oestrogen-progestogen administration in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Neuroendocrine and clinical effects of transdermal 17β-estradiol in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Treatment of postmenopausal osteoporosis with transdermal estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

21 January 2018

Calcitonin and estrogens

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

An epidemiologic study of hip fracture in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Events per person year--a dubious concept

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Postmenopausal estrogen and prevention bias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697139809085526

10.3109/13697139809085526

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference